m53r3g9m | Knowledge4COVID-19

Property	Value
?:abstract	Randomized controlled trials designed to test cancer therapies often fail to clarify effectiveness in real-world settings. Herein, we explore lessons for trial development in oncology that can be learnt from the large-cohort, pragmatic RECOVERY trial involving patients hospitalized with COVID-19.
?:creator	<https://research.tib.eu/covid-19/entity/Banerjee%2C_Rahul%3B_Prasad%2C_Vinay>
?:doi	10.1038/s41571-020-00448-y
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41571-020-00448-y>
?:journal	Nat_Rev_Clin_Oncol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/3bd4c49b19db3ac382904f7e996e2f861bdda7b8.json
?:pmc_json_files	document_parses/pmc_json/PMC7604917.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7604917>
?:pmid	<https://research.tib.eu/covid-19/entity/33139895.0>
?:pmid	33139895.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/3bd4c49b19db3ac382904f7e996e2f861bdda7b8>
?:source	Medline; PMC
?:title	Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-02

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/m53r3g9m>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/m53r3g9m>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all